1 / 16

Fondaparinux (Arixtra)

Fondaparinux (Arixtra). Patricia Croteau University of South Florida. Self administration teaching. Behavioral Objectives. State the medical reason for which Fondaparinux is being used (cognitive ).

bob
Download Presentation

Fondaparinux (Arixtra)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fondaparinux (Arixtra) Patricia Croteau University of South Florida Self administration teaching

  2. Behavioral Objectives • State the medical reason for which Fondaparinux is being used (cognitive). • Verbalize the possible side effects associated with the use of Fondaparinux (cognitive). • Verbalize the actions to take in the event a side effect of Fondaparinux should occur (cognitive). • Demonstrate the correct procedure used to administer a Fondaparinux injection with 100% accuracy (psychomotor).

  3. Target Audience • Any patient that has a history of: • deep vein thrombosis • pulmonary embolism • Any patient that is at increased risk for developing: • deep vein thromobis • pulmonary embolism * Note: Examples of patients at increased risk are any patients that have had knee replacement, hip replacement, hip surgery or abdominal surgery

  4. Environment for Learning • Patient teaching may take place • In a classroom • Some facilities conduct group teaching in a classroom for patients that are having scheduled surgeries. • Physician’s office • Some Orthopedic surgeons have their nurses conduct teaching to their patients in the office once the patient has scheduled their surgery. • Patient bedside • For patients in the hospital, most of these patients had emergency surgery so there was no time before the surgery for teaching to take place.

  5. What is Fondaparinux? • Fondaparinux (Arixtra) is a blood thinner, also known as an anticoagulant. ("Gsk source," 2011)

  6. Why do I need Fondaparinux? • Fondaparinux helps to prevent blood clots from forming in patients who have had surgery of the hip, knee, or the stomach area (abdominal surgery). • Fondaparinx is also used to treat patients who have blood clots in their legs (Deep Vein Thrombosis, DVT) or blood clots that travel to their lungs (Pulmonary Embolism, PE). ("Gsk source," 2011)

  7. DVT and PE

  8. What are some of the side effects that might occur? • Severe bleeding • Allergic reaction • Reaction at site of injections • Anemia (low red blood cell count) • Increased liver enzyme results • Insomnia ("Gsk source," 2011)

  9. What should I do if I have a side effect? Call your doctor • Call 911 OR

  10. How to administer Fondaparinux • Gather all necessary supplies: • Pre-filled medication syringe • Alcohol wipes • Gloves

  11. How to administer Fondaparinux • Wash your hands with soap & water

  12. How to administer Fondaparinux • Choose site for injection • The spot should be on your lower stomach area (abdomen), approx. 2 inches below your belly button. It is important to change sides (left/right) for each injection. • Cleanse site with alcohol wipe

  13. How to administer Fondaparinux Between your thumb and forefinger, gently pinch the skin at injection site. Insert the needle at a 90 angle. Push syringe plunger down as far as it will go. As you release the plunger the needle will be pulled up into the safety sleeve. Note: to decrease chances of bruising do not rub site after injection

  14. How to administer Fondaparinux • Properly dispose of syringe in approved sharps container

  15. CREDITS: PHOTOS: • Slide 1: http://medconnections.com/drugs/images/full/arixtra-4.jpg • Slide 7: http://www.effectivehealthcare.ahrq.gov/ehc/assets/Image/vteconsimage2.png • Slide 9 • Image 1: http://1.imimg.com/data/K/L/MY-1488601/doctor-on-call_10929741_250x250.jpg • Image 2: http://www.hall-markfire.com/florida/images/aa_hillsborough_county_EMS_sm.jpg • Slide 10 • Image 1: http://medconnections.com/drugs/images/full/arixtra-4.jpg • Image 2: Photo taken by Patricia Croteau 2012, October 11 • Slide 11: Photo taken by Patricia Croteau 2012, October 11 • Slide 12: http://3.bp.blogspot.com/_vWjkYJfw-iw/StPGOVc8ibI/AAAAAAAACGk/2u2MieBDdrI/s400/Male+Torso+-+Skin+textured+-+From+Jaguar+model_640x480.JPG • Slide 13: http://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=ProductDetailPage&product_id=1244136744215&featureKey=600552#section-42230-3 • Slide 14: http://www.lbl.gov/ehs/waste/images/pub-3095/image019.jpg

  16. References: Gsk source. (2011). Retrieved from http://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=ProductDetailPage&product_id=12441367442 15&featureKey=600552

More Related